跳至主要内容
临床试验/NCT02917486
NCT02917486已完成不适用

EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION

Rennes University Hospital2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
44
试验地点
2
主要终点
Measure exposure to piperacillin

研究概览

简要总结

The objective of the study is to investigate the exposure difference between antibiotic studied patients in intensive care with Extracorporeal Membrane Oxygenation and patients without Extracorporeal Membrane Oxygenation.

The exhibition is evaluated by population pharmacokinetic modeling.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years
  • Hospitalisation in intensive care
  • Treatment with ECMO or without ECMO
  • Introducing sepsis treated with an anti-infective molecule studied (piperacillin) for less than 48 hours
  • With an arterial catheter
  • Patient Information or their next of kin according to the patients status.

排除标准

  • Pregnancy
  • Major person under legal protection (backup justice, trusteeship, quardianship), person deprived of liberty

结局指标

主要结局

Measure exposure to piperacillin

时间窗: Day 1

evaluated by population pharmacokinetic modeling and is defined by the time during which the antibiotic concentration is greater than 4 times the critical concentration of the germ to treat

次要结局

未报告次要终点

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验